JP5001830B2 - 免疫賦活用組成物 - Google Patents
免疫賦活用組成物 Download PDFInfo
- Publication number
- JP5001830B2 JP5001830B2 JP2007503610A JP2007503610A JP5001830B2 JP 5001830 B2 JP5001830 B2 JP 5001830B2 JP 2007503610 A JP2007503610 A JP 2007503610A JP 2007503610 A JP2007503610 A JP 2007503610A JP 5001830 B2 JP5001830 B2 JP 5001830B2
- Authority
- JP
- Japan
- Prior art keywords
- food
- bifidobacteria
- strain
- bifidobacterium bifidum
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000003308 immunostimulating effect Effects 0.000 title claims description 74
- 239000000203 mixture Substances 0.000 title claims description 70
- 241000186000 Bifidobacterium Species 0.000 claims description 109
- 238000004519 manufacturing process Methods 0.000 claims description 100
- 241000186016 Bifidobacterium bifidum Species 0.000 claims description 80
- 229940002008 bifidobacterium bifidum Drugs 0.000 claims description 76
- 102400001107 Secretory component Human genes 0.000 claims description 67
- 239000000047 product Substances 0.000 claims description 58
- 235000013305 food Nutrition 0.000 claims description 57
- 230000003248 secreting effect Effects 0.000 claims description 34
- 239000008194 pharmaceutical composition Substances 0.000 claims description 32
- 239000012228 culture supernatant Substances 0.000 claims description 24
- 235000013376 functional food Nutrition 0.000 claims description 20
- 235000013361 beverage Nutrition 0.000 claims description 12
- 230000036541 health Effects 0.000 claims description 11
- 210000002490 intestinal epithelial cell Anatomy 0.000 claims description 11
- 239000000725 suspension Substances 0.000 claims description 10
- 241000894006 Bacteria Species 0.000 claims description 8
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 8
- 239000012141 concentrate Substances 0.000 claims description 7
- 239000013589 supplement Substances 0.000 claims description 7
- 235000015140 cultured milk Nutrition 0.000 claims description 4
- 239000004310 lactic acid Substances 0.000 claims description 4
- 235000014655 lactic acid Nutrition 0.000 claims description 4
- 230000000474 nursing effect Effects 0.000 claims description 2
- 230000004151 fermentation Effects 0.000 claims 1
- 238000000855 fermentation Methods 0.000 claims 1
- 210000004027 cell Anatomy 0.000 description 82
- 230000014509 gene expression Effects 0.000 description 37
- 239000000306 component Substances 0.000 description 28
- 239000002609 medium Substances 0.000 description 28
- 230000001939 inductive effect Effects 0.000 description 27
- 239000002953 phosphate buffered saline Substances 0.000 description 27
- 210000002429 large intestine Anatomy 0.000 description 21
- 238000005259 measurement Methods 0.000 description 19
- 210000001986 peyer's patch Anatomy 0.000 description 19
- 210000001519 tissue Anatomy 0.000 description 17
- 101150095279 PIGR gene Proteins 0.000 description 16
- 230000000694 effects Effects 0.000 description 16
- 238000002474 experimental method Methods 0.000 description 16
- 238000000034 method Methods 0.000 description 16
- 108090000623 proteins and genes Proteins 0.000 description 16
- 108090000890 Interferon regulatory factor 1 Proteins 0.000 description 15
- 238000002360 preparation method Methods 0.000 description 15
- 238000003556 assay Methods 0.000 description 13
- 241001608472 Bifidobacterium longum Species 0.000 description 12
- 210000004698 lymphocyte Anatomy 0.000 description 12
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 11
- 230000001965 increasing effect Effects 0.000 description 11
- 210000000813 small intestine Anatomy 0.000 description 11
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 10
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 10
- 229940009291 bifidobacterium longum Drugs 0.000 description 10
- 230000036737 immune function Effects 0.000 description 10
- 230000000968 intestinal effect Effects 0.000 description 10
- 239000007788 liquid Substances 0.000 description 10
- 239000002299 complementary DNA Substances 0.000 description 9
- 239000000463 material Substances 0.000 description 9
- 239000000523 sample Substances 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- 210000003405 ileum Anatomy 0.000 description 8
- 208000015181 infectious disease Diseases 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 7
- 239000000654 additive Substances 0.000 description 7
- 230000001580 bacterial effect Effects 0.000 description 7
- 210000002919 epithelial cell Anatomy 0.000 description 7
- 235000013350 formula milk Nutrition 0.000 description 7
- 230000036039 immunity Effects 0.000 description 7
- 239000008101 lactose Substances 0.000 description 7
- 108020004999 messenger RNA Proteins 0.000 description 7
- 230000028327 secretion Effects 0.000 description 7
- 239000003826 tablet Substances 0.000 description 7
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 6
- 239000012980 RPMI-1640 medium Substances 0.000 description 6
- 239000002775 capsule Substances 0.000 description 6
- 235000008504 concentrate Nutrition 0.000 description 6
- 210000001035 gastrointestinal tract Anatomy 0.000 description 6
- 210000003563 lymphoid tissue Anatomy 0.000 description 6
- 210000004180 plasmocyte Anatomy 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 241000186012 Bifidobacterium breve Species 0.000 description 5
- 238000002965 ELISA Methods 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- 244000269722 Thea sinensis Species 0.000 description 5
- 210000003719 b-lymphocyte Anatomy 0.000 description 5
- 239000012894 fetal calf serum Substances 0.000 description 5
- 239000008103 glucose Substances 0.000 description 5
- 238000000338 in vitro Methods 0.000 description 5
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 5
- 210000004877 mucosa Anatomy 0.000 description 5
- 244000052769 pathogen Species 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 241000286268 Bifidobacterium bifidum ATCC 29521 = JCM 1255 = DSM 20456 Species 0.000 description 4
- 102000004289 Interferon regulatory factor 1 Human genes 0.000 description 4
- 241000124008 Mammalia Species 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- 238000000692 Student's t-test Methods 0.000 description 4
- 210000000621 bronchi Anatomy 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 230000002708 enhancing effect Effects 0.000 description 4
- -1 etc.) Substances 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 239000012091 fetal bovine serum Substances 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 239000008187 granular material Substances 0.000 description 4
- 235000013402 health food Nutrition 0.000 description 4
- 210000000987 immune system Anatomy 0.000 description 4
- 210000000936 intestine Anatomy 0.000 description 4
- 230000000813 microbial effect Effects 0.000 description 4
- 239000000546 pharmaceutical excipient Substances 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 238000003753 real-time PCR Methods 0.000 description 4
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 4
- 235000013616 tea Nutrition 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 108020004414 DNA Proteins 0.000 description 3
- 101150112014 Gapdh gene Proteins 0.000 description 3
- 235000008452 baby food Nutrition 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 239000001569 carbon dioxide Substances 0.000 description 3
- 229910002092 carbon dioxide Inorganic materials 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 230000002458 infectious effect Effects 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 239000008267 milk Substances 0.000 description 3
- 210000004080 milk Anatomy 0.000 description 3
- 238000003199 nucleic acid amplification method Methods 0.000 description 3
- 210000002229 urogenital system Anatomy 0.000 description 3
- 241000251468 Actinopterygii Species 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241001655328 Bifidobacteriales Species 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 108010076119 Caseins Proteins 0.000 description 2
- 241000193403 Clostridium Species 0.000 description 2
- 108020003215 DNA Probes Proteins 0.000 description 2
- 238000000018 DNA microarray Methods 0.000 description 2
- 239000003298 DNA probe Substances 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 239000012591 Dulbecco’s Phosphate Buffered Saline Substances 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- 229930182566 Gentamicin Natural products 0.000 description 2
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- 229920001213 Polysorbate 20 Polymers 0.000 description 2
- 238000011530 RNeasy Mini Kit Methods 0.000 description 2
- 239000012979 RPMI medium Substances 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 210000001744 T-lymphocyte Anatomy 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 239000002518 antifoaming agent Substances 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 229910001424 calcium ion Inorganic materials 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 239000005018 casein Substances 0.000 description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 2
- 235000021240 caseins Nutrition 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 229960003067 cystine Drugs 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- 210000003608 fece Anatomy 0.000 description 2
- 235000019688 fish Nutrition 0.000 description 2
- 235000012041 food component Nutrition 0.000 description 2
- 229960002518 gentamicin Drugs 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 230000008944 intestinal immunity Effects 0.000 description 2
- 210000004347 intestinal mucosa Anatomy 0.000 description 2
- 230000031146 intracellular signal transduction Effects 0.000 description 2
- 210000001630 jejunum Anatomy 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 229910001425 magnesium ion Inorganic materials 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 210000004400 mucous membrane Anatomy 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 238000010899 nucleation Methods 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
- 239000003531 protein hydrolysate Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000003757 reverse transcription PCR Methods 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 229960005322 streptomycin Drugs 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 231100000033 toxigenic Toxicity 0.000 description 2
- 230000001551 toxigenic effect Effects 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- 235000013618 yogurt Nutrition 0.000 description 2
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 108010085238 Actins Proteins 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 239000000592 Artificial Cell Substances 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 108700039887 Essential Genes Proteins 0.000 description 1
- 208000004262 Food Hypersensitivity Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 101000840258 Homo sapiens Immunoglobulin J chain Proteins 0.000 description 1
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
- 108091006905 Human Serum Albumin Proteins 0.000 description 1
- 102000008100 Human Serum Albumin Human genes 0.000 description 1
- 102100029571 Immunoglobulin J chain Human genes 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- 239000004158 L-cystine Substances 0.000 description 1
- 235000019393 L-cystine Nutrition 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 244000070406 Malus silvestris Species 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 238000000585 Mann–Whitney U test Methods 0.000 description 1
- 229940123973 Oxygen scavenger Drugs 0.000 description 1
- QOPCCXBAPONXCL-KWIZKVQNSA-K P(=O)([O-])([O-])[O-].[Na+].[C@@H]1([C@H](O)[C@H](O)[C@@H](CO)O1)N1C=NC=2C(O)=NC=NC12.[Na+].[Na+] Chemical compound P(=O)([O-])([O-])[O-].[Na+].[C@@H]1([C@H](O)[C@H](O)[C@@H](CO)O1)N1C=NC=2C(O)=NC=NC12.[Na+].[Na+] QOPCCXBAPONXCL-KWIZKVQNSA-K 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 108010046644 Polymeric Immunoglobulin Receptors Proteins 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 241000219094 Vitaceae Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- VLSOAXRVHARBEQ-UHFFFAOYSA-N [4-fluoro-2-(hydroxymethyl)phenyl]methanol Chemical compound OCC1=CC=C(F)C=C1CO VLSOAXRVHARBEQ-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 235000021016 apples Nutrition 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- LFYJSSARVMHQJB-QIXNEVBVSA-N bakuchiol Chemical compound CC(C)=CCC[C@@](C)(C=C)\C=C\C1=CC=C(O)C=C1 LFYJSSARVMHQJB-QIXNEVBVSA-N 0.000 description 1
- 235000013527 bean curd Nutrition 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 235000020299 breve Nutrition 0.000 description 1
- 238000010805 cDNA synthesis kit Methods 0.000 description 1
- 235000012970 cakes Nutrition 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 235000012174 carbonated soft drink Nutrition 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- KXKPYJOVDUMHGS-OSRGNVMNSA-N chondroitin sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](OS(O)(=O)=O)[C@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](C(O)=O)O1 KXKPYJOVDUMHGS-OSRGNVMNSA-N 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 235000020152 coffee milk drink Nutrition 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 229960002433 cysteine Drugs 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 235000021245 dietary protein Nutrition 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 235000015071 dressings Nutrition 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 229940007062 eucalyptus extract Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 210000003499 exocrine gland Anatomy 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 235000020932 food allergy Nutrition 0.000 description 1
- 239000005428 food component Substances 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical class OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 description 1
- 229940107187 fructooligosaccharide Drugs 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000020710 ginseng extract Nutrition 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 235000021021 grapes Nutrition 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 239000007952 growth promoter Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 230000008076 immune mechanism Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000015788 innate immune response Effects 0.000 description 1
- 230000004068 intracellular signaling Effects 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 239000011344 liquid material Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000008204 material by function Substances 0.000 description 1
- 239000008268 mayonnaise Substances 0.000 description 1
- 235000010746 mayonnaise Nutrition 0.000 description 1
- 239000012533 medium component Substances 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 229960004452 methionine Drugs 0.000 description 1
- 244000005706 microflora Species 0.000 description 1
- 235000020124 milk-based beverage Nutrition 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 238000001823 molecular biology technique Methods 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 208000010753 nasal discharge Diseases 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 235000020333 oolong tea Nutrition 0.000 description 1
- 239000007968 orange flavor Substances 0.000 description 1
- 125000001477 organic nitrogen group Chemical group 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 235000015927 pasta Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 235000020991 processed meat Nutrition 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 108010009004 proteose-peptone Proteins 0.000 description 1
- 235000011962 puddings Nutrition 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 235000020185 raw untreated milk Nutrition 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- JAOZKJMVYIWLKU-UHFFFAOYSA-N sodium 7-hydroxy-8-[(4-sulfonaphthalen-1-yl)diazenyl]naphthalene-1,3-disulfonic acid Chemical compound C1=CC=C2C(=C1)C(=CC=C2S(=O)(=O)O)N=NC3=C(C=CC4=CC(=CC(=C43)S(=O)(=O)O)S(=O)(=O)O)O.[Na+] JAOZKJMVYIWLKU-UHFFFAOYSA-N 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 235000010288 sodium nitrite Nutrition 0.000 description 1
- 235000019830 sodium polyphosphate Nutrition 0.000 description 1
- 235000014214 soft drink Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229940030961 sorghum extract Drugs 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 235000013322 soy milk Nutrition 0.000 description 1
- 229940001941 soy protein Drugs 0.000 description 1
- 235000013555 soy sauce Nutrition 0.000 description 1
- 235000015040 sparkling wine Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 239000006068 taste-masking agent Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 108091008023 transcriptional regulators Proteins 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 235000015192 vegetable juice Nutrition 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 235000021119 whey protein Nutrition 0.000 description 1
- 235000014101 wine Nutrition 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/517—Bifidum
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
Description
(b) Bifidobacterium bifidum OLB 6378株(受託番号 NITE BP-31)
本発明では、分泌成分産生誘導能と高いIgA産生誘導能とを備えた、ビフィドバクテリウム・ビフィダム(Bifidobacterium bifidum)に属するビフィズス菌を用いて、免疫賦活用組成物を製造する。
本発明では、上記のような本発明のビフィズス菌を含有する組成物を、免疫賦活用組成物として用いることができる。また、本発明のビフィズス菌に追加して、あるいはそれに代えて、本発明のビフィズス菌の処理物を含有する組成物を、免疫賦活用組成物として用いてもよい。本発明の免疫賦活用組成物は、腸管上皮細胞などの粘膜上皮細胞からの分泌成分の産生を誘導(促進)し、かつ、パイエル板細胞をはじめとする粘膜関連リンパ組織におけるIgA産生を高レベルに誘導(促進)する。
本発明は、分泌成分産生誘導能および高いIgA産生誘導能を有するビフィドバクテリウム・ビフィダムに属するビフィズス菌および/またはそのビフィズス菌の処理物を含有する免疫賦活用組成物を添加した、飲食品にも関する。本明細書において「飲食品」とは、限定するものではないが、飲料、食品および機能性食品を包含する。
本発明は、分泌成分産生誘導能および高いIgA産生誘導能を有するビフィドバクテリウム・ビフィダムに属するビフィズス菌および/またはそのビフィズス菌の処理物を含有する免疫賦活用組成物を有効成分として含有する、医薬組成物にも関する。
1. ビフィズス菌の調製
Bifidobacterium longum OLB 6001株(受託番号 FERM P-13610)、Bifidobacterium bifidum OLB 6377株(受託番号 NITE BP-30)、Bifidobacterium bifidum OLB 6378株(受託番号 NITE BP-31)、Bifidobacterium breve株(受託番号FERM BP-2824)およびBifidobacterium bifidum MEP170212(以前の名称:Bifidobacterium bifidum #1(明冶)株;本菌株は明治乳業株式会社(日本)が保有している)を、それぞれ、グルコースをラクトースに変更して調製した嫌気EG培地で37℃にて一夜培養した。なお嫌気EG培地は以下の組成に従って調製した。
40.0 g (1リットル当たり)
肉エキス・・・・・・・・・・2.6 g
プロテオーゼペプトン・・・・10.0 g
酵母エキス・・・・・・・・・5.0 g
リン酸一水素ナトリウム・・・4.0 g
ラクトース・・・・・・・・・1.5 g
溶性デンプン・・・・・・・・0.5 g
L−シスチン・・・・・・・・0.2 g
L−システイン塩酸塩・・・・0.5 g
消泡剤(シリコン)・・・・・0.2 g
ポリソルベート80・・・・・0.5 g
カンテン・・・・・・・・・ 15.0 g
pH 7.7
得られた培養物中の菌体を冷PBS(-)で2回洗浄した後、少量のPBS(-)に懸濁し、等量の8%-ホルマリン-PBSに懸濁して菌体を固定した。この固定した菌体から、IgA産生誘導能の測定実験を行う当日に冷PBS(-)で洗浄することによりホルマリンを除去した後、菌液をPBSに懸濁して660 nmでの濁度が1.6となるように菌液濃度を調整した。こうして得られた菌液をホルマリン処理済ビフィズス菌液と呼ぶこととした。
8週齢のBALB/Cマウス(メス)を炭酸ガス気流下に50秒間さらすことにより殺し、無菌的に切り出された小腸からパイエル板を採取した。このパイエル板を少量の2%ウシ胎児血清を含むRPMI-1640培地(Gibco)中に取り出し、Suzukiらの方法(スライド法;Bifidobacteria Microflora, 9: 87-98, 1990)を一部改変してパイエル板細胞を調製した。すなわち、採取したパイエル板を少量の2%ウシ胎児血清を含むRPMI-1640培地(Gibco社)を入れたシャーレ上に取り出し、解剖用のメスの刃で切り刻み、プラスチックシリンジの柄(テルモ社)を用いて徐々に押しほぐした。こうして得られた細胞懸濁液を150ゲージの滅菌ステンレス鋼ふるいを通過させ、さらに2%ウシ胎児血清を含むRPMI-1640培地にて2回洗浄した。細胞を適当量の2%ウシ胎児血清を含むRPMI-1640培地に再懸濁し、T細胞およびB細胞を含むリンパ細胞群(パイエル板細胞)を得た。
1. ビフィズス菌破砕物の調製
Bifidobacterium bifidum OLB 6377株、Bifidobacterium bifidum OLB 6378株、Bifidobacterium bifidum MEP170212(以前の名称:Bifidobacterium bifidum #1(明治)株;本菌株は明治乳業株式会社(日本)が保有している)およびBifidobacterium bifidum MEP170222(以前の名称:Bifidobacterium bifidum #2(明治)株;本菌株は明治乳業株式会社(日本)が保有している)のそれぞれを、実施例1と同様にして、グルコースをラクトースに変更して調製した嫌気EG培地において一夜培養した。次いで、得られた培養物中の菌体を冷PBS(-)で2回洗浄してから、PBS(-)中に10 mg/mlにて懸濁した。この懸濁物を75℃で60分間かけて加熱処理した後、超音波破砕機(BRANSON SONIFIER250、Duty cycle: 60%、Output control: 2 micro tip limit)にかけて、菌体破砕物を得た。
ヒト腸管上皮細胞由来であるHT-29細胞を12ウェルプレートに3〜6×105個/ウェル程度になるように播種し、10%ウシ胎児血清を含むMcCoy's 5A培地(invitrogen社製)1.0 mlを加えた。翌日、上記「1. ビフィズス菌破砕物の調製」に従って調製した4菌株のビフィズス菌(Bifidobacterium bifidum OLB 6377株、Bifidobacterium bifidum OLB 6378株、Bifidobacterium bifidum MEP170212およびBifidobacterium bifidum MEP170222)由来の菌体破砕物を、上記で調製した12ウェルプレートのそれぞれ3つのウェルの培地に、菌体破砕物濃度50〜500μg/mlになるように添加し、37℃で48時間培養した。対照実験には菌体破砕物の代わりにPBS(-)[CaおよびMgイオンを除去したDulbecco's Phosphate Buffered Saline]を用いた。得られた培養物から培養上清を採取し、培養上清中の分泌成分濃度をELISA法で測定した。このため、まずELISA プレートのウェルを、ヒト分泌成分に対するポリクローナル抗体(DAKO社、PBS(-)にて1000倍希釈して使用)を用いて4℃で一晩コーティングした後、0.01% tween 20加PBS(-)で洗浄し、次いで1% ウシ血清アルブミン(BSA)- PBS(-)を加えて室温にて1時間インキュベートしブロッキングした。次にこのプレートの各ウェルに、上記で得られた各培養上清の50μlをサンプルとして加え、室温で一時間インキュベートした。各ウェルを0.01% tween 20加PBS(-)で洗浄後、ホースラディッシュペルオキシダーゼ標識した抗ヒト分泌成分抗体(DAKO社、1% BSA- PBS(-)にて1000倍希釈)を添加し、室温で30分間インキュベートした。次いで各ウェルを0.01% tween 20加PBS(-)で洗浄後、オルトフェニレンジアミン/過酸化水素水溶液100μlを各ウェルに入れ、30分間反応させた。反応後、2NH2SO4 20μlを添加して反応を停止させたのち、測定波長490nmで吸光度を測定した。測定結果は対照の分泌成分産生量を1としたときの相対値で示した。各群間の有意
差検定は、スチューデントt-検定により、危険率5%以下で有意差の有無を判定した。
出産された後24時間以内のBALB/cマウスから回腸および近位大腸を摘出し、器官培養したものを検討に用いた。すなわち、回腸および近位大腸を輪切りにして幅約2〜4mmの組織片を調製した。組織片をガラス濾紙上でシート状に縦方向に切り開き、筋板側の面をガラス濾紙に密着させた。作成した組織シートを48ウェルプレートに入れ、100 U/mlペニシリン(萬有製薬)、0.1 mg/mlストレプトマイシン(明治製菓)、0.05 mg/ml ゲンタマイシン(LIFE TECHNOLOGIES)、および10%ウシ胎児血清入りのRPMI培地(日水製薬)0.5mlを加えた。
以上のようにして算出されたpIgR遺伝子相対発現量に基づき、複数の実験サンプルからpIgR遺伝子の相対発現量の平均値を算出した結果を表5および図5に示す。
胎生18日目のBALB/cマウスから回腸および近位大腸を摘出し、器官培養したものを検討に用いた。上記実施例3と同様に、回腸および近位大腸を輪切りにして幅約2〜4mmの組織片を調製した。組織片をガラス濾紙上でシート状に縦方向に切り開き、筋板側の面をガラス濾紙に密着させた。作成した組織シートを48ウェルプレートに入れ、100 U/mlペニシリン(萬有製薬)、0.1 mg/mlストレプトマイシン(明治製菓)、0.05 mg/ml ゲンタマイシン(LIFE TECHNOLOGIES)、および10%ウシ胎児血清入りのDMEM培地(Gibco)0.5mlを加えた。
基本的には実施例2の方法に従って、ビフィズス菌Bifidobacterium bifidum OLB 6378株とBifidobacterium bifidum JCM 1255T株の分泌成分産生誘導能を測定し、比較した。なおBifidobacterium bifidum JCM 1255T株は、比較用の株として、独立行政法人 理化学研究所バイオリソースセンター 微生物材料開発室(JCM)(日本国埼玉県和光市広沢2-1)より入手した。
Claims (7)
- 腸管上皮細胞における分泌成分産生量を少なくとも1.2倍に増加させる分泌成分産生誘導能を有するビフィドバクテリウム・ビフィダム(Bifidobacterium bifidum)に属するビフィズス菌および/または該ビフィズス菌の処理物を含有することを特徴とする、免疫賦活用組成物であって、該分泌成分は分泌型IgAを構成する成分であり、前記ビフィズス菌が、Bifidobacterium bifidum OLB 6377株(受託番号 NITE BP-30)またはBifidobacterium bifidum OLB 6378株(受託番号 NITE BP-31)である、免疫賦活用組成物。
- 前記ビフィズス菌の処理物が、ビフィズス菌の懸濁物、培養物、培養上清、発酵物、加熱処理物、破砕物、濃縮物、ペースト化物、乾燥物および希釈物からなる群より選択される少なくとも1つである、請求項1記載の免疫賦活用組成物。
- 請求項1または2記載の免疫賦活用組成物を含む飲食品。
- 乳児用食品、幼児用食品、授乳婦用食品、高齢者用食品、病者用食品、保健機能食品、サプリメント、発酵乳および乳酸菌飲料からなる群から選択される、請求項3記載の飲食品。
- 請求項1または2記載の免疫賦活用組成物を含む、医薬組成物。
- 免疫賦活用の飲食品または医薬組成物を製造するための、Bifidobacterium bifidum OLB 6377株(受託番号 NITE BP-30)またはBifidobacterium bifidum OLB 6378株(受託番号 NITE BP-31)の使用。
- 下記(a)または(b)のビフィズス菌。
(a) Bifidobacterium bifidum OLB 6377株(受託番号 NITE BP-30)
(b) Bifidobacterium bifidum OLB 6378株(受託番号 NITE BP-31)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007503610A JP5001830B2 (ja) | 2005-02-02 | 2006-02-01 | 免疫賦活用組成物 |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005026631 | 2005-02-02 | ||
JP2005026631 | 2005-02-02 | ||
JP2005256835 | 2005-09-05 | ||
JP2005256835 | 2005-09-05 | ||
PCT/JP2006/301661 WO2006087913A1 (ja) | 2005-02-02 | 2006-02-01 | 免疫賦活用組成物 |
JP2007503610A JP5001830B2 (ja) | 2005-02-02 | 2006-02-01 | 免疫賦活用組成物 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPWO2006087913A1 JPWO2006087913A1 (ja) | 2008-07-03 |
JP5001830B2 true JP5001830B2 (ja) | 2012-08-15 |
Family
ID=36916323
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2007503610A Active JP5001830B2 (ja) | 2005-02-02 | 2006-02-01 | 免疫賦活用組成物 |
Country Status (9)
Country | Link |
---|---|
US (1) | US7943124B2 (ja) |
EP (1) | EP1854467B8 (ja) |
JP (1) | JP5001830B2 (ja) |
KR (1) | KR101234435B1 (ja) |
CN (1) | CN101151041B (ja) |
AU (1) | AU2006215205B2 (ja) |
CA (1) | CA2596680C (ja) |
HK (1) | HK1116667A1 (ja) |
WO (1) | WO2006087913A1 (ja) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2138186A1 (en) * | 2008-06-24 | 2009-12-30 | Nestec S.A. | Probiotics, secretory IgA and inflammation |
EP2138187A1 (en) * | 2008-06-24 | 2009-12-30 | Nestec S.A. | Probiotics, secretory IgA and infection |
EP2147678A1 (en) * | 2008-07-21 | 2010-01-27 | Nestec S.A. | Probiotics to increase IgA secretion in infants born by caesarean section |
CN103179975B (zh) | 2010-08-31 | 2015-07-15 | 国立大学法人新潟大学 | 肠道免疫调节剂 |
WO2014119605A1 (ja) * | 2013-01-29 | 2014-08-07 | 日東薬品工業株式会社 | ビフィズス菌を含有する安定な組成物 |
SG11201707793YA (en) * | 2015-05-29 | 2017-10-30 | Meiji Co Ltd | Anticariogenic agent and anticariogenic composition |
US20180311289A1 (en) * | 2015-10-19 | 2018-11-01 | Meiji Co., Ltd. | Infection protective agent for infants |
AU2017251028A1 (en) * | 2016-04-13 | 2018-11-29 | Meiji Co., Ltd. | Brain function-improving composition for newborns |
JP2018177703A (ja) * | 2017-04-14 | 2018-11-15 | 株式会社明治 | Toll様受容体2活性化用組成物 |
TW202015712A (zh) * | 2018-07-03 | 2020-05-01 | 學校法人北里研究所 | 用以抑制流感之重症化的抗流感病毒劑 |
KR102485269B1 (ko) * | 2019-10-18 | 2023-01-06 | 주식회사 지놈앤컴퍼니 | 비피도박테리움 비피덤을 포함하는 면역력 증강 또는 개선용 조성물 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002053472A (ja) * | 2000-05-31 | 2002-02-19 | Yakult Honsha Co Ltd | 脂質過酸化抑制剤 |
JP2002255853A (ja) * | 2001-03-01 | 2002-09-11 | Biofuerumin Seiyaku Kk | 免疫賦活組成物 |
JP2003201239A (ja) * | 2001-11-05 | 2003-07-18 | Meiji Milk Prod Co Ltd | 免疫賦活食品組成物 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07106142B2 (ja) | 1989-04-21 | 1995-11-15 | 株式会社ヤクルト本社 | IgA誘導能を有するビフィドバクテリウム・ロンガム又はビフィドバクテリウム・ブレーベ |
JP2968374B2 (ja) * | 1991-05-16 | 1999-10-25 | 株式会社ヤクルト本社 | IgA産生促進剤 |
JP3269890B2 (ja) * | 1993-08-25 | 2002-04-02 | 株式会社ヤクルト本社 | ワクチンの効果増強剤及び効果増強食品 |
JPH0769907A (ja) | 1993-08-27 | 1995-03-14 | Meiji Milk Prod Co Ltd | 日和見感染症防御用組成物 |
JPH07106142A (ja) | 1993-09-29 | 1995-04-21 | Taiyo Yuden Co Ltd | トロイダルコイル |
FR2848115B1 (fr) * | 2002-12-05 | 2005-03-25 | Rhodia Chimie Sa | Composition de bacteries et son utilisation |
JP2004262773A (ja) * | 2003-02-17 | 2004-09-24 | Ryoshoku Kenkyukai | 免疫機能改善を目的としたビフィズス菌製剤 |
JP2005089388A (ja) * | 2003-09-18 | 2005-04-07 | Biofuerumin Seiyaku Kk | 免疫賦活作用増強剤 |
-
2006
- 2006-02-01 WO PCT/JP2006/301661 patent/WO2006087913A1/ja active Application Filing
- 2006-02-01 CN CN2006800104644A patent/CN101151041B/zh active Active
- 2006-02-01 CA CA2596680A patent/CA2596680C/en not_active Expired - Fee Related
- 2006-02-01 AU AU2006215205A patent/AU2006215205B2/en not_active Ceased
- 2006-02-01 EP EP06712804.1A patent/EP1854467B8/en not_active Not-in-force
- 2006-02-01 JP JP2007503610A patent/JP5001830B2/ja active Active
- 2006-02-01 KR KR1020077020013A patent/KR101234435B1/ko active IP Right Grant
- 2006-02-01 US US11/815,136 patent/US7943124B2/en active Active
-
2008
- 2008-06-25 HK HK08107058.6A patent/HK1116667A1/xx not_active IP Right Cessation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002053472A (ja) * | 2000-05-31 | 2002-02-19 | Yakult Honsha Co Ltd | 脂質過酸化抑制剤 |
JP2002255853A (ja) * | 2001-03-01 | 2002-09-11 | Biofuerumin Seiyaku Kk | 免疫賦活組成物 |
JP2003201239A (ja) * | 2001-11-05 | 2003-07-18 | Meiji Milk Prod Co Ltd | 免疫賦活食品組成物 |
Also Published As
Publication number | Publication date |
---|---|
CA2596680A1 (en) | 2006-08-24 |
US7943124B2 (en) | 2011-05-17 |
CA2596680C (en) | 2013-06-18 |
AU2006215205A1 (en) | 2006-08-24 |
AU2006215205B2 (en) | 2011-05-19 |
KR101234435B1 (ko) | 2013-02-18 |
EP1854467A1 (en) | 2007-11-14 |
EP1854467B1 (en) | 2018-08-15 |
CN101151041A (zh) | 2008-03-26 |
CN101151041B (zh) | 2012-12-05 |
EP1854467A4 (en) | 2011-11-16 |
WO2006087913A1 (ja) | 2006-08-24 |
HK1116667A1 (en) | 2009-01-02 |
US20090142374A1 (en) | 2009-06-04 |
KR20070100413A (ko) | 2007-10-10 |
EP1854467B8 (en) | 2018-09-26 |
JPWO2006087913A1 (ja) | 2008-07-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5001830B2 (ja) | 免疫賦活用組成物 | |
US10570366B2 (en) | Lactic acid bacterium having IgA production promoting activity, and use thereof | |
KR20110018898A (ko) | 자연 면역을 증가시키는 프로바이오틱인 단리된 락토바실러스 플란타룸 균주 인듀시아 dsm 21379와, 이를 포함하는 식품과 의약적 제제 | |
KR101640744B1 (ko) | 고분자 다당 바인더에 컨쥬게이트된 락토바실러스 람노서스 rht-3201, 및 이의 아토피 예방 및 치료 용도 | |
JP7179343B2 (ja) | 新規な乳酸菌株およびそれを含む免疫賦活剤 | |
CN111212575A (zh) | 肌肉增量用组合物 | |
TW200804591A (en) | Lactic acid bacterium having immunoregulatory activity derived from moromi for wine fermentation | |
WO2018168449A1 (ja) | ペプチドグリカン認識タンパク質産生促進用組成物 | |
KR102001074B1 (ko) | 충치 억제 활성을 갖는 유산균 조성물 | |
CA3090043A1 (en) | Postbiotic-based composition for the modulation of immune system activation and protection of mucosal barriers | |
KR102230517B1 (ko) | 충치 억제 활성을 갖는 락토바실러스 살리바리우스를 포함하는 조성물 | |
WO2020067422A1 (ja) | T細胞を活性化するための組成物 | |
WO2018003898A1 (ja) | 軟骨再生促進用組成物 | |
TW201609120A (zh) | 含乳酸菌之腸道屏障功能促進劑 | |
WO2017175774A1 (ja) | インターフェロンλ産生促進用組成物及びその製造方法 | |
JP6999061B1 (ja) | 免疫賦活用組成物、風邪様症状予防剤、及びウイルス感染予防剤 | |
JP7387113B2 (ja) | 新規ラクトバチルス属乳酸菌 | |
JP2009254236A (ja) | 新規乳酸菌並びに新規乳酸菌を利用した飲食品及び免疫賦活剤 | |
JP2024046233A (ja) | 腸管バリアの改善のための組成物 | |
WO2011025019A1 (ja) | チオレドキシン誘導活性を有する乳酸菌ならびにチオレドキシンを介する生体傷害の予防および/または改善用の飲食品および医薬品 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20090122 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120117 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120316 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20120508 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20120518 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5001830 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20150525 Year of fee payment: 3 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |